Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|2|3|379-392

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.2, Iss.3, 2002-09, pp. : 379-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite

Phosphonolipids as non-viral vectors for gene therapy

By Floch V.   Le Bolc'h G.   Gable-Guillaume C.   Le Bris N.   Yaouanc J.-J.   des Abbayes H.   Ferec C.   Clement J.-C.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 923-934

Elsevier

Access to resources Recommend Favorite

Epstein-Barr virus and multiple sclerosis: association or causation?

By Pakpoor Julia   Giovannoni Gavin   Ramagopalan Sreeram V  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Epstein–Barr virus: novel patented therapeutics

By De Paoli Paolo  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 807-818

Informa Healthcare

Access to resources Recommend Favorite

Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 629-641

Bentham Science Publishers

Access to resources Recommend Favorite